BK vs CRBU · P/E 17, $94.14B cap vs rev $3.9M
The Bank of New York Mellon Corporation (BK) versus Caribou Biosciences Inc (CRBU) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
BK does not have a complete income-statement cache yet.
Latest reported CRBU revenue for 2026-06-30 was $3.9M. Net income was -$49.4M. Revenue was up 62.5% from 2026-03-31 to 2026-06-30. CRBU currently screens at market cap $190.4M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. CRBU currently screens at market cap $190.4M.
Not investment advice. Open the BK and CRBU stock pages for the full models.
Not investment advice.